other important considerations include formulation technology, the efficiency of active ingredient delivery into the epidermis , and supporting ingredients like Azelaic Acid that help maintain the skin barrier
PT-141 helps re-engage those pathways, making it easier to reignite that mental spark and support a physical response
At the higher doses, results were very consistent: All participants lost at least 5% of their body weight Around 3 in 4 lost 15% or more With placebo, only around 1 in 4 lost 5% or more Phase 3 update (TRIUMPH-4, 68 weeks, topline results) In December 2025 , Eli Lilly shared early (topline) results from a larger phase 3 study (TRIUMPH-4)
Gupta-Ganguli, M., Cox, K., Means, B., Gerling, I
Daha yksek yzde peinde komaktansa stabil formlasyon nemlidir